Ingebrigt Sylte

3.4k total citations
127 papers, 2.7k citations indexed

About

Ingebrigt Sylte is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Ingebrigt Sylte has authored 127 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 41 papers in Cellular and Molecular Neuroscience and 27 papers in Oncology. Recurrent topics in Ingebrigt Sylte's work include Receptor Mechanisms and Signaling (45 papers), Neuroscience and Neuropharmacology Research (23 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Ingebrigt Sylte is often cited by papers focused on Receptor Mechanisms and Signaling (45 papers), Neuroscience and Neuropharmacology Research (23 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Ingebrigt Sylte collaborates with scholars based in Norway, Poland and United States. Ingebrigt Sylte's co-authors include Svein G. Dahl, Aina Westrheim Ravna, Olayiwola A. Adekoya, Jan‐Olof Winberg, Øyvind Edvardsen, Osman Gani, Lars Uhlin‐Hansen, Elin Hadler‐Olsen, Zdzisław Chilmończyk and Andrzej J. Bojarski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Ingebrigt Sylte

126 papers receiving 2.7k citations

Peers

Ingebrigt Sylte
Peter Hodder United States
Takatsugu Hirokawa Japan
Raj Kumar United States
Henry J. Lin United States
Dan Chen China
Abdul H. Fauq United States
Csaba Hetényi Hungary
Jiyoun Lee South Korea
Julian A. Simon United States
John Matsoukas Greece
Peter Hodder United States
Ingebrigt Sylte
Citations per year, relative to Ingebrigt Sylte Ingebrigt Sylte (= 1×) peers Peter Hodder

Countries citing papers authored by Ingebrigt Sylte

Since Specialization
Citations

This map shows the geographic impact of Ingebrigt Sylte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingebrigt Sylte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingebrigt Sylte more than expected).

Fields of papers citing papers by Ingebrigt Sylte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingebrigt Sylte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingebrigt Sylte. The network helps show where Ingebrigt Sylte may publish in the future.

Co-authorship network of co-authors of Ingebrigt Sylte

This figure shows the co-authorship network connecting the top 25 collaborators of Ingebrigt Sylte. A scholar is included among the top collaborators of Ingebrigt Sylte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingebrigt Sylte. Ingebrigt Sylte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haj‐Yasein, Nadia Nabil, Jørn E. Tungen, Jason Matthews, et al.. (2019). Molecular modelling, synthesis, and biological evaluations of a 3,5-disubstituted isoxazole fatty acid analogue as a PPARα-selective agonist. Bioorganic & Medicinal Chemistry. 27(18). 4059–4068. 7 indexed citations
3.
Sylte, Ingebrigt, et al.. (2017). Specific interactions between zinc metalloproteinase and its inhibitors: Ab initio fragment molecular orbital calculations. Journal of Molecular Graphics and Modelling. 75. 277–286. 5 indexed citations
4.
Odunuga, Odutayo O., Olayiwola A. Adekoya, & Ingebrigt Sylte. (2015). High-level expression of pseudolysin, the extracellular elastase of Pseudomonas aeruginosa, in Escherichia coli and its purification. Protein Expression and Purification. 113. 79–84. 9 indexed citations
5.
Chilmończyk, Zdzisław, Andrzej J. Bojarski, & Ingebrigt Sylte. (2014). Ligand-directed trafficking of receptor stimulus. Pharmacological Reports. 66(6). 1011–1021. 6 indexed citations
6.
Larsen, Anett Kristin, Kurt Kristiansen, Ingebrigt Sylte, Ole Morten Seternes, & Berit Bang. (2013). Differences in PAR-2 activating potential by king crab (Paralithodes camtschaticus), salmon (Salmo salar), and bovine (Bos taurus) trypsin. BMC Research Notes. 6(1). 281–281. 2 indexed citations
7.
8.
Kufareva, Irina, et al.. (2013). Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5). Theoretical Biology and Medical Modelling. 10(1). 56–56. 12 indexed citations
9.
Khan, Mahmud Tareq Hassan, Toshiro Matsui, Noriyuki Kurita, et al.. (2012). Dipeptide Inhibitors of Thermolysin and Angiotensin I-Converting Enzyme. Current Topics in Medicinal Chemistry. 12(16). 1748–1762. 6 indexed citations
10.
Sylte, Ingebrigt, et al.. (2011). A short update on the structure of drug binding sites on neurotransmitter transporters. BMC Research Notes. 4(1). 559–559. 4 indexed citations
11.
Ravna, Aina Westrheim, et al.. (2011). Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516. Bioorganic & Medicinal Chemistry. 19(23). 6982–6988. 4 indexed citations
12.
Hadler‐Olsen, Elin, et al.. (2010). Regulation of matrix metalloproteinase activity in health and disease. FEBS Journal. 278(1). 28–45. 298 indexed citations
13.
Kostenko, Sergiy, Mahmud Tareq Hassan Khan, Ingebrigt Sylte, & Ugo Moens. (2010). The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor. Cellular and Molecular Life Sciences. 68(2). 289–301. 9 indexed citations
14.
Ravna, Aina Westrheim, Ingebrigt Sylte, & Georg Sager. (2008). A molecular model of a putative substrate releasing conformation of multidrug resistance protein 5 (MRP5). European Journal of Medicinal Chemistry. 43(11). 2557–2567. 25 indexed citations
15.
Gani, Osman & Ingebrigt Sylte. (2008). Molecular recognition of Docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor α. Journal of Molecular Graphics and Modelling. 27(2). 217–224. 43 indexed citations
16.
Dahl, Svein G. & Ingebrigt Sylte. (2005). Molecular Modelling of Drug Targets: The Past, the Present and the Future. Basic & Clinical Pharmacology & Toxicology. 96(3). 151–155. 25 indexed citations
17.
Våbenø, Jon, Carsten Uhd Nielsen, Bente Steffansen, et al.. (2005). Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs. Bioorganic & Medicinal Chemistry. 13(6). 1977–1988. 6 indexed citations
18.
Dahl, Svein G., Kurt Kristiansen, & Ingebrigt Sylte. (2002). Bioinformatics: from genome to drug targets. Annals of Medicine. 34(4). 306–312. 10 indexed citations
19.
Sylte, Ingebrigt, Øyvind Edvardsen, & Svein G. Dahl. (1993). Molecular dynamics of the 5-HT1a receptor and ligands. Protein Engineering Design and Selection. 6(7). 691–700. 26 indexed citations
20.
Sylte, Ingebrigt & Svein G. Dahl. (1991). Molecular Structure and Dynamics of cis(Z)- and trans(E)-Flupenthixol and Clopenthixol. Pharmaceutical Research. 8(4). 462–470. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hodder Breakdown of academic impact, for papers by Takatsugu Hirokawa Breakdown of academic impact, for papers by Raj Kumar Breakdown of academic impact, for papers by Henry J. Lin Breakdown of academic impact, for papers by Dan Chen Breakdown of academic impact, for papers by Abdul H. Fauq Breakdown of academic impact, for papers by Csaba Hetényi Breakdown of academic impact, for papers by Jiyoun Lee Breakdown of academic impact, for papers by Julian A. Simon Breakdown of academic impact, for papers by John Matsoukas
Rankless by CCL
2026